Germany’s CureVac AG is about to launch third phase clinical trials of its coronavirus vaccine candidate, the company’s CEO, Franz-Werner Haas, said on Thursday. The jab could get final approval by September 2021. … Read More >German company says its Covid-19 vaccine could be ready for use by September 2021